304 related articles for article (PubMed ID: 30081037)
1. Glia-specific APOE epigenetic changes in the Alzheimer's disease brain.
Tulloch J; Leong L; Thomson Z; Chen S; Lee EG; Keene CD; Millard SP; Yu CE
Brain Res; 2018 Nov; 1698():179-186. PubMed ID: 30081037
[TBL] [Abstract][Full Text] [Related]
2. The APOE Gene is Differentially Methylated in Alzheimer's Disease.
Foraker J; Millard SP; Leong L; Thomson Z; Chen S; Keene CD; Bekris LM; Yu CE
J Alzheimers Dis; 2015; 48(3):745-55. PubMed ID: 26402071
[TBL] [Abstract][Full Text] [Related]
3. Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease.
Lee EG; Tulloch J; Chen S; Leong L; Saxton AD; Kraemer B; Darvas M; Keene CD; Shutes-David A; Todd K; Millard S; Yu CE
PLoS One; 2020; 15(1):e0227667. PubMed ID: 31978088
[TBL] [Abstract][Full Text] [Related]
4. APOE DNA methylation is altered in Lewy body dementia.
Tulloch J; Leong L; Chen S; Keene CD; Millard SP; Shutes-David A; Lopez OL; Kofler J; Kaye JA; Woltjer R; Nelson PT; Neltner JH; Jicha GA; Galasko D; Masliah E; Leverenz JB; Yu CE; Tsuang D
Alzheimers Dement; 2018 Jul; 14(7):889-894. PubMed ID: 29544979
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM
J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex.
Gasparoni G; Bultmann S; Lutsik P; Kraus TFJ; Sordon S; Vlcek J; Dietinger V; Steinmaurer M; Haider M; Mulholland CB; Arzberger T; Roeber S; Riemenschneider M; Kretzschmar HA; Giese A; Leonhardt H; Walter J
Epigenetics Chromatin; 2018 Jul; 11(1):41. PubMed ID: 30045751
[TBL] [Abstract][Full Text] [Related]
7. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
8. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.
Bekris LM; Galloway NM; Montine TJ; Schellenberg GD; Yu CE
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):409-417. PubMed ID: 19554612
[TBL] [Abstract][Full Text] [Related]
9. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications in Alzheimer's disease: cause or effect?
Piaceri I; Raspanti B; Tedde A; Bagnoli S; Sorbi S; Nacmias B
J Alzheimers Dis; 2015; 43(4):1169-73. PubMed ID: 25159670
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic signature and enhancer activity of the human APOE gene.
Yu CE; Cudaback E; Foraker J; Thomson Z; Leong L; Lutz F; Gill JA; Saxton A; Kraemer B; Navas P; Keene CD; Montine T; Bekris LM
Hum Mol Genet; 2013 Dec; 22(24):5036-47. PubMed ID: 23892237
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
Nagata K; Mano T; Murayama S; Saido TC; Iwata A
Neurosci Lett; 2018 Mar; 670():8-13. PubMed ID: 29339171
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation in the APOE genomic region is associated with cognitive function in African Americans.
Liu J; Zhao W; Ware EB; Turner ST; Mosley TH; Smith JA
BMC Med Genomics; 2018 May; 11(1):43. PubMed ID: 29739406
[TBL] [Abstract][Full Text] [Related]
14. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M
Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984
[TBL] [Abstract][Full Text] [Related]
15. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
16. Specific regional transcription of apolipoprotein E in human brain neurons.
Xu PT; Gilbert JR; Qiu HL; Ervin J; Rothrock-Christian TR; Hulette C; Schmechel DE
Am J Pathol; 1999 Feb; 154(2):601-11. PubMed ID: 10027417
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
18. Epigenetically regulated microRNAs in Alzheimer's disease.
Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
[TBL] [Abstract][Full Text] [Related]
19. Altered glia-neuron communication in Alzheimer's Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.
Soelter TM; Howton TC; Clark AD; Oza VH; Lasseigne BN
Cell Commun Signal; 2024 Jun; 22(1):317. PubMed ID: 38849813
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene.
Lahiri DK
J Mol Neurosci; 2004; 23(3):225-33. PubMed ID: 15181251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
